Fundz

Piramal Pharma Ltd. To Invest Minority Stake In Yapan Bio, India-Based Cdmo Providing Expertise In Biologics And Vaccines

RECENTLY ACQUIREDDec 21, 2021

Round Type

Funding Round

HyderabadManufacturingBiotechnology

Description

Piramal Pharma Limited (PPL) today announced an investment of INR101.77cr in Yapan Bio Pvt Ltd ("Yapan") of Hyderabad, India, augmenting the capabilities of its Contract Development and Manufacturing Organization (CDMO) business, Piramal Pharma Solutions (PPS). PPL holds 27.78% equity stake in the company as a result of this investment. As PPS continues to strengthen its capabilities and position itself as a leading CDMO, this acquisition marks a significant addition to PPS' global capabilities in the development and manufacturing of large molecules for human clinical trials.

Quick answer

Yapan Bio Private Limited raised an undisclosed amount in a Funding Round round, dated December 21, 2021. Yapan Bio Private Limited is based in Hyderabad, Telangana, India.

How much did Yapan Bio Private Limited raise?
Yapan Bio Private Limited raised an undisclosed amount in a Funding Round round on December 21, 2021.
What does Yapan Bio Private Limited do?
Yapan Bio Private Limited is a Contract Development and Manufacturing Organization (CDMO) specializing in vaccines and biologics.
Where is Yapan Bio Private Limited based and how big is it?
Yapan Bio Private Limited is based in Hyderabad, Telangana, India. Fundz records about 55 employees.

Source: Fundz verified event record.

Who else raised in Manufacturing and Biotechnology around the same time

Companies in the same sectors as Yapan Bio Private Limited that raised within 45 days of this round, from Fundz verified event records.

  • Advanced NanoTherapies raised $9.2M on January 26, 2022.
  • Talphera, Inc. raised $5.2M on January 24, 2022.
  • Sway raised $2.5M (Seed) on January 19, 2022.
  • Varda Space Industries raised $2.8M (Seed) on January 18, 2022.
  • Co-Diagnostics, Inc. raised $47M on January 14, 2022.
  • MycoWorks, Inc. raised $125M (Series C) on January 13, 2022.

Who to call at Yapan Bio Private Limited, and when

A new round usually means Yapan Bio Private Limited is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Yapan Bio Private Limited raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Yapan Bio Private Limited, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Yapan Bio Private Limited. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Yapan Bio Private Limited

Location

Hyderabad, Telangana, India

About

Yapan Bio Private Limited is a Contract Development and Manufacturing Organization (CDMO) specializing in vaccines and biologics. The company is focused on providing large molecule capabilities and plays a key role in advancing biologic therapies. Yapan Bio is now a subsidiary of Piramal Pharma Limited.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Yapan Bio Private Limited raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Yapan Bio Private Limited's next move

See what Strategic adds

Yapan Bio Private Limited raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.